New Delhi: The Indian government is holding talks with Johnson and Johnson for its single dose COVID-19 vaccine.
“We are in talks with Johnson & Johnson regarding their single-dose vaccine. Their vaccine is being produced outside,” Niti Ayog (health) member Dr VK Paul said during a press briefing on Friday.
Dr Paul also informed that the vaccine developed by the US pharmaceutical giant will be produced at Hyderabad-based Indian company Bio E.
“As per the plan, this vaccine will also be produced in Hyderabad’s Biological E,” Dr Paul said.
Johnson & Johnson recently said its vaccine is far more effective in neutralising Delta variants than against Beta variants.
Besides Covishield and Covaxin, India has approved two other vaccines so far — Moderna and Sputnik V.
Bhubaneswar: The night temperature in Odisha is likely to rise by 2-4 degree Celsius during…
Bhubaneswar: Director General of Sashastra Seema Bal (SSB) Amrit Mohan Prasad, an IPS officer of…
Bhubaneswar: A male elephant under treatment at Nandankanan Zoological Park, on the outskirts of Bhubaneswar,…
Bhubaneswar: Prime Minister Narendra Modi is scheduled to travel to Odisha, his second visit to…
Bhubaneswar: Soon after the successful anti-Maoist operation in Chhattisgarh in which Odisha’s SOG played an…
Bhubaneswar: A total of 157 men, including transgenders, had applied under Subhadra Yojana, the fund…
This website uses cookies.
